BIOSQUARE 2010

We have made some hard choices. We took no aspect of the event for granted. What’s more, with some outside help, we managed to ask our participants and ourselves some tough questions. Their wishes and our instincts tell us that the industry wants efficiency and results, not a potpourri of endless options. Like we said, expect an intense 34 hours.

Those of you, who have attended BioSquare are in for a surprise when you come to Geneva next February 2010. You will see how much effort we have put into reinventing the event; a must in critical times. You will be impressed by our scouting efforts; we are scouring the planet for mature opportunities to make sure they are here. You will be pleased by the venue; we are making certain your experience is more pleasant and efficient than ever. You will be delighted by the financial profile of investors; you will see that we have aimed higher, not lower. Finally, you will be satisfied by our logistics; we are committed to a pragmatic event that seats you face to face with the right deal.
Of particular importance, BioSquare is making the bold step into bioconvergence. It is the place where pharmaceuticals, biotechs, nanotechs, medtechs, in silicos and their related partners meet to deal.
And if you have never been to BioSquare before, this is a great year to start.
And the future…? We imagine an event that continues to be the best place to meet partners that are ‘ready for the deal’.